Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A man developed skin issues from cancer medication, which improved with specific treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Soy isoflavones can protect lung tissue from radiation damage.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Understanding where cancer cells come from helps create better prevention and treatment methods.